Lakeshore Biopharma (LSB) Stock Price, News & Analysis

Company Overview

LakeShore Biopharma Co., Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.

Key Stats

• Today's Range: $2.23 to $2.39
• 50-Day Range: $2.25 to $3.70
• 52-Week Range: $1.88 to $11.20
• Volume: 12,414 shs
• Average Volume: 6,802 shs
• Market Capitalization: $20.90 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LSB Stock Analysis - Frequently Asked Questions

How have LSB shares performed this year?

Lakeshore Biopharma's stock was trading at $3.46 at the beginning of the year. Since then, LSB stock has decreased by 35.1% and is now trading at $2.2450.
View the best growth stocks for 2025 here.

When did Lakeshore Biopharma's stock split?

Shares of Lakeshore Biopharma reverse split before market open on Friday, October 4th 2024. The 1-10 reverse split was announced on Friday, September 27th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Lakeshore Biopharma's major shareholders?

Lakeshore Biopharma's top institutional investors include Orbimed Advisors LLC (1.51%), Hhlr Advisors LTD. (0.81%) and Barclays PLC (0.27%).

How do I buy shares of Lakeshore Biopharma?

Shares of LSB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Lakeshore Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lakeshore Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

• Today: 2/22/2025
• Fiscal Year End: 3/31/2025
• Next Earnings (Estimated): 4/18/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:LSB
• Previous Symbol: NASDAQ:LSB
• CUSIP: N/A
• CIK: 1946399
• Web: N/A
• Phone: 17327133678
• Fax: N/A
• Employees: 773
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.13
• Current Ratio: 1.17
• Quick Ratio: 0.90

Sales & Book Value

• Annual Sales: $80.82 million
• Price / Sales: 0.26
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $8.86 per share
• Price / Book: 0.25

Miscellaneous

• Outstanding Shares: 9,310,000
• Free Float: N/A
• Market Cap: $20.90 million
• Optionable: N/A
• Beta: 0.66